# Feature Audit: Bug #82 PR Context Not Bundled Extension-Side

**Timestamp:** 2026-03-09T11-40  
**Base branch:** `origin/development`  
**Feature folder:** `docs/features/active/2026-03-09-pr-context-not-bundled-extension-side-82`

## 1) Scope and Baseline

Evidence sources used for this audit:
- Primary PR context summary: `artifacts/pr_context.summary.txt`
- Baseline diff appendix: `artifacts/pr_context.appendix.txt`
- Feature scoping docs: `issue.md`, `spec.md`
- Direct code and test inspection in `extensions/drm-copilot/*`
- Fresh verification commands run in this session (TS + Python toolchain)

Work mode marker:
- `issue.md` contains `- Work Mode: full`
- Therefore AC source is `spec.md` + `issue.md` acceptance list supplied in request.

## 2) Acceptance Criteria Inventory (authoritative for this run)

1. Extension spawns `python <bundled_script_path>` (NOT `python -m`)  
2. Bundled script resolves and imports bundled package via `sys.path` manipulation  
3. `--repo-root` is passed explicitly with workspace path  
4. Output artifacts written relative to destination workspace  
5. Branch discovery and QuickPick UX unchanged  
6. TypeScript tests pass with updated assertions  
7. `executePythonModule` and `PythonModuleCommandSpec` removed  
8. Repro steps now produce expected behavior  
9. Regression tests added and passing

## 3) Acceptance Criteria Evaluation

| Criterion | Status | Evidence | Verification command(s) | Notes |
|---|---|---|---|---|
| 1 | PASS | `extension.ts` uses `executeBundledScript` with `bundledRelativePath: resources/templates/collect_pr_context.py`; tests assert first arg is script path, not `-m`. | `npm run test:unit` | Unit/integration assertions directly guard this behavior. |
| 2 | PASS | Wrapper `_ensure_bundled_scripts_import_path()` inserts `resources/scripts`; imports `dev_tools.pr_context.collector`. | File inspection | No collector business logic duplicated in wrapper. |
| 3 | PASS | `extension.ts` args include `--repo-root`, `workspaceRoot`; tests assert value exactly. | `npm run test:unit` | Includes unicode/space workspace path case. |
| 4 | PASS | Command runs with destination `cwd`; args write to `artifacts/pr_context.summary.txt` + `appendix.txt`; integration tests verify output paths. | `npm run test:unit` | Relative artifact paths remain destination-workspace relative. |
| 5 | PASS | Branch discovery (`discoverPrBaseBranches`) and QuickPick flow unchanged; tests cover default choice and cancel behavior. | `npm run test:unit` | No UX contract change observed. |
| 6 | PASS | Jest: 3 suites, 37 tests, all pass. | `npm run test:unit` | Updated assertions validated. |
| 7 | PASS | No `executePythonModule` / `PythonModuleCommandSpec` in current `extension.ts`. | Source inspection/search | Dead code removed as requested. |
| 8 | PASS | Root cause (`ModuleNotFoundError` from destination `-m` path) removed by bundled-script execution pattern; integration tests model destination workspace behavior. | `npm run test:unit` + static diff review | Consider optional manual VS Code host smoke test in release checklist. |
| 9 | PASS | Added/updated regression tests in collect-pr-context and integration test files assert bundled execution and argument propagation. | `npm run test:unit` | Regression guard coverage present and green. |

## 4) Additional Required Validation from Spec/Policy

| Check | Status | Evidence |
|---|---|---|
| Full TS toolchain pass | PASS | `npm run lint`, `npm run typecheck`, `npm run test:unit` all pass. |
| Full Python toolchain pass | PASS | `poetry run black --check .`, `ruff check`, `pyright`, `pytest --cov=...` pass. |
| Coverage threshold | PASS | Pytest coverage total 81% (meets `>=80%`). |
| No unintended behavior changes outside scope | PASS | Changes localized to PR-context command path, wrapper, bundled package, and corresponding tests. |

## 5) Summary

**Overall feature readiness:** **PASS**  
**Recommendation:** Ready to open/merge PR into `origin/development` after standard CI.

No remediation artifacts are required for this audit run because there are no FAIL/PARTIAL acceptance criteria and no blocker findings.
